Lexicon Pharmaceuticals
LXRX
$1.57
Share price
-0.63%
Change (1 day)
-34.31%
Change (1 year)
Categories
Lexicon Pharmaceuticals (LXRX) - P/B ratio
P/B ratio as of April 2024 : 2.79
According to Lexicon Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 2.79.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Lexicon Pharmaceuticals - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | 4.02 | 30.77% |
| 2022-12-31 | 3.08 | -40.41% |
| 2021-12-31 | 5.16 | 66.88% |
| 2020-12-31 | 3.09 | -17.83% |
| 2019-12-31 | 3.77 | -114.14% |
| 2018-12-31 | -26.6 | -274.31% |
| 2017-12-31 | 15.3 | 67.18% |
| 2016-12-31 | 9.14 | 89.45% |
| 2015-12-31 | 4.82 | 107.92% |
| 2014-12-31 | 2.32 | -57.26% |
| 2013-12-31 | 5.43 | 27.86% |
| 2012-12-31 | 4.25 | 190.06% |
| 2011-12-31 | 1.46 | -25.57% |
| 2010-12-31 | 1.97 | 7.66% |
| 2009-12-31 | 1.83 | 86.81% |
| 2008-12-31 | 0.9780 | -32.38% |
| 2007-12-31 | 1.45 | -55.97% |
| 2006-12-31 | 3.29 | 19.62% |
| 2005-12-31 | 2.75 | -32.18% |
| 2004-12-31 | 4.05 | 81.88% |
| 2003-12-31 | 2.23 | 52.71% |
| 2002-12-31 | 1.46 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 4.67 | 67.61% | 🇺🇸 USA |
 Illumina ILMN | 3.39 | 21.55% | 🇺🇸 USA |
 Regeneron Pharmaceuticals REGN | 3.73 | 33.84% | 🇺🇸 USA |
 Ultragenyx RARE | 13.2 | 374.26% | 🇺🇸 USA |
 Ligand Pharmaceuticals LGND | 1.78 | -36.08% | 🇺🇸 USA |
 Esperion Therapeutics ESPR | -0.7909 | -128.36% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | 3.10 | 11.20% | 🇺🇸 USA |
 Eterna Therapeutics ERNA | 4.34 | 55.51% | 🇺🇸 USA |